Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Abbott LaboratoriesXSWX:ABT +1.64%78 3-Year Book Growth Rate is 12.40% as of Jun. 2026, which is 22% above its 10-year median of 10.20. GuruFocus rates XSWX:ABT with a GF Score™ of 78/100 and a GF Value™ of CHF105.37. The stock has 2 warning signs investors should review. Among 759 Medical Devices & Instruments companies, Abbott Laboratories ranks better than 78.39% on this metric.
During the past 12 months, Abbott Laboratories's average Book Value per Share Growth Rate was 1.70% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 12.40% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 10.20% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 7.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Abbott Laboratories was 19.20% per year. The lowest was -5.30% per year. And the median was 10.20% per year.
Abbott Laboratories (XSWX:ABT) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Abbott Laboratories 3-Year Book Growth Rate Related Terms
XSWX:ABT vs SYK, MDT, BSX: 3-Year Book Growth Rate Comparison
For the Medical Devices subindustry, Abbott Laboratories's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories 3-Year Book Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's 3-Year Book Growth Rate falls into.
Abbott Laboratories 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 12.40% mean?
Abbott Laboratories (XSWX:ABT) has a 3-Year Book Growth Rate of 12.40% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Abbott Laboratories and its competitors. This is 22% above median its historical median of 10.20. According to the industry distribution chart, Abbott Laboratories ranks #164 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 21.6%.
Is Abbott Laboratories' 3-Year Book Growth Rate too high?
Abbott Laboratories' current 3-Year Book Growth Rate of 12.40% is 22% above median its 10-year median of 10.20. The Medical Devices & Instruments industry median 3-Year Book Growth Rate is 2.30. Abbott Laboratories' value of 12.40% is 439.1% above this industry median. Based on the distribution chart, Abbott Laboratories ranks #164 out of 759 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Abbott Laboratories has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' 3-Year Book Growth Rate compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #164 out of 759 companies for 3-Year Book Growth Rate. This places Abbott Laboratories in the top 22% of its industry — outperforming the majority of peers. The industry median 3-Year Book Growth Rate is 2.30. Abbott Laboratories' value of 12.40% is 439.1% above this benchmark. While the company's 10-year median is 10.20 vs. the industry median of 2.30, Abbott Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Book Growth Rate among Medical Devices & Instruments companies is 2.30, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current 3-Year Book Growth Rate of 12.40% is 439.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Abbott Laboratories and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Book Growth Rate is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current 3-Year Book Growth Rate is 12.40%, which is 22% above median its own 10-year median of 10.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current 3-Year Book Growth Rate of 12.40%. The stock's GF Value™ is CHF105.37, compared to a current price of CHF93.00 — trading 11.7% below its estimated fair value. The current 3-Year Book Growth Rate is 12.40%, which is 22% above median its 10-year median of 10.20 and 439.1% above the Medical Devices & Instruments industry median of 2.30. Abbott Laboratories' overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current 3-Year Book Growth Rate is 12.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of CHF93.00 is trading 11.7% below its estimated GF Value™ of CHF105.37.
Key valuation signals for XSWX:ABT:
3-Year Book Growth Rate: 12.40% (22% above median its 10-year median of 10.20)
GF Value™: CHF105.37 vs. price of CHF93.00 (11.7% below fair value)
Industry Position: 439.1% above the Medical Devices & Instruments median (#164 of 759)
No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
78GF Score
Get the complete analysis for XSWX:ABT
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ABT has been successfully added to your 
